Sonoma Pharmaceuticals, Inc. (SNOA) compared with its closest peers (SINT, INBS, CODX, NVNO, PMI). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Sintx Technologies, Inc. (SINT) | $9.93M | -0.6 |
| Intelligent Bio Solutions Inc. (INBS) | $8.14M | -0.9 |
| Co-Diagnostics, Inc. (CODX) | $7.25M | -0.0 |
| enVVeno Medical Corporation (NVNO) | $7.18M | -0.0 |
| Picard Medical, Inc. (PMI) | $7.09M | -2.3 |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.20M | — |
| Bluejay Diagnostics, Inc. (BJDX) | $4.11M | -0.0 |
| Catheter Precision, Inc. (VTAK) | $4.03M | -0.1 |
| Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) | $2.08M | -0.2 |
| INVO Fertility, Inc. (IVF) | $1.93M | — |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
SNOA overview · SNOA earnings · SNOA financials · SNOA KPIs · SNOA investor relations · SNOA ownership · SNOA filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.